Physician profile
James Thelbert Fields
NPI 1023087277
$791.18
in general payments reported to CMS, 2019-2025
20 companies · $9.48 in 2025
The $9.48 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $241 · 2021: $243 · 2022: $61.62 · 2024: $80.85 · 2025: $9.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zealand Pharma US, INC. | $158.87 | 2021-2022 | |
| Lilly USA, LLC | $114.06 | 2020-2021 | |
| Novo Nordisk INC | $72.94 | 2019-2024 | Wegovy |
| Abbott Laboratories | $53.90 | 2019-2024 | Freestyle Libre 3 |
| Amgen INC. | $50.40 | 2019 | |
| Radius Health, INC. | $42.74 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $34.55 | 2019-2020 | |
| Abbvie INC. | $32.65 | 2021 | |
| Arbor Pharmaceuticals, INC. | $31.40 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $25.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $25.25 | 2019-2020 | |
| Edwards Lifesciences Corporation | $23.58 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $20.76 | 2021 | |
| Boston Scientific Corporation | $18.01 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $15.05 | 2020 | |
| Allergan, INC. | $12.98 | 2020 | |
| Astellas Pharma US INC | $12.26 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 | |
| Phathom Pharmaceuticals, INC. | $9.48 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.